(Q41128544)

27 September 2017

1 reference

title

Modulation of sympathetic outflow by centrally acting antihypertensive drugs (English)

1 reference

27 September 2017

P A van Zwieten

1

1 reference

27 September 2017

publication date

1 June 1996

1 reference

Cardiovascular Drugs and Therapy

27 September 2017

published in

1 reference

27 September 2017

volume

10 Suppl 1

1 reference

27 September 2017

page(s)

283-289

1 reference

Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit

27 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00120498

Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors

21 January 2018

1 reference

12 December 2020

Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area.

1 reference

12 December 2020

Overview of alpha 2-adrenoceptor agonists with a central action

1 reference

12 December 2020

Insulin-like partial effects of agmatine derivatives in adipocytes

1 reference

12 December 2020

Cardiac hypertrophy and antihypertensive therapy

1 reference

12 December 2020

.alpha.2 Adrenoceptors: classification, localization, mechanisms and targets for drugs

1 reference

12 December 2020

Drugs interacting with alpha adrenoceptors

1 reference

12 December 2020

Involvement of brain 5-HT1A receptors in the hypotensive response to urapidil

1 reference

12 December 2020

Clinical pharmacology of imidazolines and related compounds

1 reference

12 December 2020

Serotonergic receptors and drugs in hypertension

1 reference

12 December 2020

Therapy of hypertensive cardiac hypertrophy and impaired coronary microcirculation

1 reference

12 December 2020

Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla

1 reference

12 December 2020

Importance of imidazoline receptors in the cardiovascular responses to clonidine and rilmenidine in conscious rabbits

1 reference

12 December 2020

Central serotonergic mechanisms in cardiovascular regulation.

1 reference

12 December 2020

An imidazoline-specific mechanism for the hypotensive effect of clonidine: a study with yohimbine and idazoxan

1 reference

12 December 2020

Different types of centrally acting antihypertensives and their targets in the central nervous system

1 reference

12 December 2020

Brainstem and bulbospinal neurotransmitter systems in the control of blood pressure

1 reference

12 December 2020

Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.

1 reference

12 December 2020

The hypotensive activity and side effects of methyldopa, clonidine, and guanfacine

1 reference

12 December 2020

Moxonidine. A review of its pharmacology, and therapeutic use in essential hypertension

1 reference

12 December 2020

Are there multiple imidazoline binding sites?

1 reference

12 December 2020

Different types of centrally acting antihypertensive drugs.

1 reference

12 December 2020

Ageing, serotonin and ketanserin

1 reference

12 December 2020

Central hypotensive activity of ketanserin in cats.

1 reference

12 December 2020

Central 5-HT1A receptors and the mechanism of the central hypotensive effect of (+)8-OH-DPAT, DP-5-CT, R28935, and urapidil.

1 reference

12 December 2020

Urapidil, a multiple-action alpha-blocking drug

1 reference

12 December 2020

Keeping an eye on the I site: imidazoline-preferring receptors

1 reference

12 December 2020

Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00120498

1 reference

27 September 2017

1 reference